KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)R&D In ProcessReceivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Gilead Sciences (GILD) Leases (2019 - 2025)

Gilead Sciences filings provide 10 years of Leases readings, the most recent being $532.0 million for Q4 2025.

  • On a quarterly basis, Leases rose 3.3% to $532.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $532.0 million, a 3.3% increase, with the full-year FY2025 number at $532.0 million, up 3.3% from a year prior.
  • Leases hit $532.0 million in Q4 2025 for Gilead Sciences, up from $515.0 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $581.0 million in Q4 2023 to a low of $505.0 million in Q4 2022.
  • Median Leases over the past 5 years was $532.0 million (2025), compared with a mean of $535.0 million.
  • Biggest five-year swings in Leases: fell 16.1% in 2021 and later grew 15.05% in 2023.
  • Gilead Sciences' Leases stood at $542.0 million in 2021, then fell by 6.83% to $505.0 million in 2022, then increased by 15.05% to $581.0 million in 2023, then dropped by 11.36% to $515.0 million in 2024, then rose by 3.3% to $532.0 million in 2025.
  • The last three reported values for Leases were $532.0 million (Q4 2025), $515.0 million (Q4 2024), and $581.0 million (Q4 2023) per Business Quant data.